Demand for SARS-CoV-2 Antigen Tests Shows No Signs of Slowing as Netherlands Orders 9.2 Million Tests from BD
The Netherlands recently developed a national structure to ensure systematic distribution of SARS-CoV-2 testing and supplies for significantly expanding COVID-19 testing capacity. In the US, wide use of these antigen tests presents two key opportunities for clinical laboratories.
FDA Issues EUA for First COVID-19 Test That Detects Neutralizing Antibodies
With over 50 COVID-19 antibody tests authorized for use under FDA EUA, a milestone has been recognized with the FDA’s Nov. 6, 2020, announcement.
Pooled Testing: What Your Lab Needs to Know About Managing a Fall/Winter Surge in the COVID-19 Pandemic
Gain a clear understanding of when it makes sense to implement pooled testing, specifically for COVID-19, understand the potential benefits of pooled testing, as well as learn the important features to look for when selecting pooled testing workflow technology.
FDA Releases Updated SARS-CoV-2 Antigen Testing Template
Key update and recommendations released Oct. 26, 2020, that affect SARS-CoV-2 antigen test use.
CMS Amends Repayment Terms for Loans Made to Providers During the COVID-19 Public Health Emergency
October 2020 Medicare loan repayment update for providers.
Greek Scientists Develop New Tool Leveraging Clinical Laboratory Test Grouping to Predict Individuals’ COVID-19 Disease Severity
A particular grouping of several blood tests is needed to utilize this disease severity score. The predictive value of such clinical laboratory testing as a risk assessment model could drive an increase in seven key lab tests.
FDA Approves First COVID-19 Antiviral Treatment That May Increase Testing Volumes for Clinical Laboratories
Three types of clinical laboratory testing support were stipulated with first FDA approval of antiviral drug for COVID-19 treatment.
FDA Updates Comparative Performance Data to Include Most Available SARS-CoV-2 Diagnostic Tests
New FDA update to comparative COVID-19 test performance data now includes information about most available SARS-CoV-2 diagnostic molecular tests.
Clinical Laboratory Supply Shortages Are Beginning to Affect More Than Just COVID-19 Testing
Some 122 clinical laboratories reveal how supply shortages extend beyond COVID-19 testing supplies.
NIH Awards $234 Million to Improve COVID-19 Testing for Underserved Populations
Possible new source of partnership for clinical laboratories for COVID-19 testing, especially in established networks.